ZIMMER BIOMET HOLDINGS, INC. Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax
ZIMMER BIOMET HOLDINGS, INC. (ZBH) reported Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax of $62.70 million for the 3-month period ending 2018-06-30, per its 10-Q filed 2018-08-06.
Discontinued › Income Statement › Other Income
us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax · last filed 2018-08-06
- ZIMMER BIOMET HOLDINGS, INC. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, before tax for the quarter ending 2018-06-30 was $62.70M.
- ZIMMER BIOMET HOLDINGS, INC. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, before tax for the quarter ending 2018-03-31 was -$33.10M.
- ZIMMER BIOMET HOLDINGS, INC. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, before tax for the quarter ending 2017-12-31 was -$17.00M, a 115.37% decline year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, before tax for the quarter ending 2017-09-30 was -$35.90M.
- ZIMMER BIOMET HOLDINGS, INC. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, before tax for fiscal 2017 was -$116.00M, a 490.57% decline from fiscal 2016.
- ZIMMER BIOMET HOLDINGS, INC. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, before tax for fiscal 2016 was $29.70M, a 49.75% decline from fiscal 2015.
- ZIMMER BIOMET HOLDINGS, INC. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, before tax for fiscal 2015 was $59.10M, a 2.31% decline from fiscal 2014.
- ZIMMER BIOMET HOLDINGS, INC. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, before tax for fiscal 2014 was $60.50M, a 4.87% decline from fiscal 2013.
| Period end | Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax 3 month | Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax 6 month | Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax 9 month | Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax 12 month |
|---|---|---|---|---|
| 2018-06-30 | $62.70M 10-Q · filed 2018-08-06 | $29.60M 10-Q · filed 2018-08-06 | $12.60M derived: sum of 3 quarters · filed 2018-08-06 | -$23.30M derived: sum of 4 quarters · filed 2018-08-06 |
| 2018-03-31 | -$33.10M 10-Q · filed 2018-05-08 | -$50.10M derived: sum of 2 quarters · filed 2018-05-08 | -$86.00M derived: sum of 3 quarters · filed 2018-05-08 | -$112.50M derived: sum of 4 quarters · filed 2018-08-06 |
| 2017-12-31 | -$17.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$52.90M derived: sum of 2 quarters · filed 2018-02-27 | -$79.40M derived: sum of 3 quarters · filed 2018-08-06 | -$116.00M 10-K · filed 2018-02-27 |
| 2017-09-30 | -$35.90M 10-Q · filed 2017-11-06 | -$62.40M derived: sum of 2 quarters · filed 2018-08-06 | -$99.00M 10-Q · filed 2017-11-06 | $11.60M derived: sum of 4 quarters · filed 2018-08-06 |
| 2017-06-30 | -$26.50M 10-Q · filed 2018-08-06 | -$63.10M 10-Q · filed 2018-08-06 | $47.50M derived: sum of 3 quarters · filed 2018-08-06 | $31.40M derived: sum of 4 quarters · filed 2018-08-06 |
| 2017-03-31 | -$36.60M 10-Q · filed 2018-05-08 | $74.00M derived: sum of 2 quarters · filed 2018-05-08 | $57.90M derived: sum of 3 quarters · filed 2018-05-08 | $49.60M derived: sum of 4 quarters · filed 2018-05-08 |
| 2016-12-31 | $110.60M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $94.50M derived: sum of 2 quarters · filed 2018-02-27 | $86.20M derived: sum of 3 quarters · filed 2018-02-27 | $29.70M 10-K · filed 2018-02-27 |
| 2016-09-30 | -$16.10M 10-Q · filed 2017-11-06 | -$24.40M derived: sum of 2 quarters · filed 2017-11-06 | -$80.90M 10-Q · filed 2017-11-06 | -$69.80M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | -$8.30M 10-Q · filed 2017-08-08 | -$64.80M 10-Q · filed 2017-08-08 | -$53.70M derived: sum of 3 quarters · filed 2018-02-27 | -$46.40M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | -$56.50M 10-Q · filed 2017-05-09 | -$45.40M derived: sum of 2 quarters · filed 2018-02-27 | -$38.10M derived: sum of 3 quarters · filed 2018-02-27 | -$49.10M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $11.10M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $18.40M derived: sum of 2 quarters · filed 2018-02-27 | $7.40M derived: sum of 3 quarters · filed 2018-02-27 | $59.10M 10-K · filed 2018-02-27 |
| 2015-09-30 | $7.30M 10-Q · filed 2015-11-09 | -$3.70M derived: sum of 2 quarters · filed 2016-11-08 | $48.00M 10-Q · filed 2016-11-08 | $61.20M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | -$11.00M 10-Q · filed 2016-08-08 | $40.70M 10-Q · filed 2016-08-08 | $53.90M derived: sum of 3 quarters · filed 2017-03-01 | $116.70M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $51.70M 10-Q · filed 2016-05-10 | $64.90M derived: sum of 2 quarters · filed 2017-03-01 | $127.70M derived: sum of 3 quarters · filed 2017-03-01 | $116.10M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $13.20M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $76.00M derived: sum of 2 quarters · filed 2017-03-01 | $64.40M derived: sum of 3 quarters · filed 2017-03-01 | $60.50M 10-K · filed 2017-03-01 |
| 2014-09-30 | $62.80M 10-Q · filed 2015-11-09 | $51.20M derived: sum of 2 quarters · filed 2015-11-09 | $47.30M 10-Q · filed 2015-11-09 | $64.60M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | -$11.60M 10-Q · filed 2015-08-10 | -$15.50M 10-Q · filed 2015-08-10 | $1.80M derived: sum of 3 quarters · filed 2016-02-29 | -$19.60M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | -$3.90M 10-Q · filed 2015-05-07 | $13.40M derived: sum of 2 quarters · filed 2016-02-29 | -$8.00M derived: sum of 3 quarters · filed 2016-02-29 | $14.90M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | $17.30M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$4.10M derived: sum of 2 quarters · filed 2016-02-29 | $18.80M derived: sum of 3 quarters · filed 2016-02-29 | $63.60M 10-K · filed 2016-02-29 |
| 2013-09-30 | -$21.40M 10-Q · filed 2014-11-05 | $1.50M derived: sum of 2 quarters · filed 2014-11-05 | $46.30M 10-Q · filed 2014-11-05 | $77.20M derived: sum of 4 quarters · filed 2015-02-23 |
| 2013-06-30 | $22.90M 10-Q · filed 2014-08-07 | $67.70M 10-Q · filed 2014-08-07 | $98.60M derived: sum of 3 quarters · filed 2015-02-23 | $52.20M derived: sum of 4 quarters · filed 2015-02-23 |
| 2013-03-31 | $44.80M 10-Q · filed 2014-05-06 | $75.70M derived: sum of 2 quarters · filed 2015-02-23 | $29.30M derived: sum of 3 quarters · filed 2015-02-23 | $52.00M derived: sum of 4 quarters · filed 2015-02-23 |
| 2012-12-31 | $30.90M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-23 | -$15.50M derived: sum of 2 quarters · filed 2015-02-23 | $7.20M derived: sum of 3 quarters · filed 2015-02-23 | $15.20M 10-K · filed 2015-02-23 |
| 2012-09-30 | -$46.40M 10-Q · filed 2013-11-12 | -$23.70M derived: sum of 2 quarters · filed 2013-11-12 | -$15.70M 10-Q · filed 2013-11-12 | |
| 2012-06-30 | $22.70M 10-Q · filed 2013-08-07 | $30.70M 10-Q · filed 2013-08-07 | ||
| 2012-03-31 | $8.00M 10-Q · filed 2013-05-08 | |||
| 2011-12-31 | -$34.90M 10-K · filed 2014-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |